171 related articles for article (PubMed ID: 35922954)
21. Outcomes of adult acute lymphoblastic leukemia in the era of pediatric-inspired regimens: a single-center experience.
Tantiworawit A; Rattanathammethee T; Chai-Adisaksopha C; Rattarittamrong E; Norasetthada L
Int J Hematol; 2019 Sep; 110(3):295-305. PubMed ID: 31161483
[TBL] [Abstract][Full Text] [Related]
22. Pediatric-Inspired Treatment Regimens for Adolescents and Young Adults With Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia: A Review.
Siegel SE; Stock W; Johnson RH; Advani A; Muffly L; Douer D; Reed D; Lewis M; Freyer DR; Shah B; Luger S; Hayes-Lattin B; Jaboin JJ; Coccia PF; DeAngelo DJ; Seibel N; Bleyer A
JAMA Oncol; 2018 May; 4(5):725-734. PubMed ID: 29450465
[TBL] [Abstract][Full Text] [Related]
23. [Long-term destiny of adolescents and young adults with de novo acute lymphoblastic leukemia treated with a pediatric protocol type].
López-Hernández MA; Alvarado-Ibarra M; Álvarez-Veral JL; Ortiz-Zepeda M; Guajardo-Leal ML; Cota-Range X
Gac Med Mex; 2016; 152(5):439-443. PubMed ID: 27792701
[TBL] [Abstract][Full Text] [Related]
24. The treatment of adolescents and young adults with acute lymphoblastic leukemia.
Advani AS; Hanna R
Leuk Lymphoma; 2020 Jan; 61(1):18-26. PubMed ID: 31452423
[TBL] [Abstract][Full Text] [Related]
25. Controversies in the Treatment of Adolescents and Young Adults with Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia.
Grover P; Muffly L
Curr Oncol Rep; 2022 Aug; 24(8):995-1001. PubMed ID: 35353349
[TBL] [Abstract][Full Text] [Related]
26. Optimal therapy for acute lymphoblastic leukemia in adolescents and young adults.
Schafer ES; Hunger SP
Nat Rev Clin Oncol; 2011 May; 8(7):417-24. PubMed ID: 21629213
[TBL] [Abstract][Full Text] [Related]
27. An MRD-stratified pediatric protocol is as deliverable in adolescents and young adults as in children with ALL.
Greenwood M; Trahair T; Sutton R; Osborn M; Kwan J; Mapp S; Howman R; Anazodo A; Wylie B; D'Rozario J; Hertzberg M; Irving I; Yeung D; Coyle L; Jager A; Engeler D; Venn N; Frampton C; Wei AH; Bradstock K; Dalla-Pozza L
Blood Adv; 2021 Dec; 5(24):5574-5583. PubMed ID: 34662896
[TBL] [Abstract][Full Text] [Related]
28. A pediatric regimen for older adolescents and young adults with acute lymphoblastic leukemia: results of CALGB 10403.
Stock W; Luger SM; Advani AS; Yin J; Harvey RC; Mullighan CG; Willman CL; Fulton N; Laumann KM; Malnassy G; Paietta E; Parker E; Geyer S; Mrózek K; Bloomfield CD; Sanford B; Marcucci G; Liedtke M; Claxton DF; Foster MC; Bogart JA; Grecula JC; Appelbaum FR; Erba H; Litzow MR; Tallman MS; Stone RM; Larson RA
Blood; 2019 Apr; 133(14):1548-1559. PubMed ID: 30658992
[TBL] [Abstract][Full Text] [Related]
29. New developments in ALL in AYA.
Boissel N
Hematology Am Soc Hematol Educ Program; 2022 Dec; 2022(1):190-196. PubMed ID: 36485092
[TBL] [Abstract][Full Text] [Related]
30. Prognostic impact of TP53 mutations in adult acute lymphoblastic leukemia treated with a pediatric-type regimen.
Ou J; Xu X; Deng S; Liang H; Cai Z; Li J; Huang Z; Tang B; Wang Z; Zhou Y; Liu X; Liu Q; Zhou H
Leuk Lymphoma; 2024 Feb; 65(2):219-227. PubMed ID: 37938093
[TBL] [Abstract][Full Text] [Related]
31. Improved survival in adolescents and young adults (AYA) patients aged 14-55 years with acute lymphoblastic leukemia using pediatric-inspired protocol - a retrospective analysis of a real-world experience in 79 of patients treated at a national tertiary care referral center.
Hanbali A; Kotb A; Fakih RE; Alfraih F; Ahmed SO; Shaheen M; Alhayli S; Alahmari A; Alotaibi A; Alshaibani A; Riash MA; Deeba F; Asif M; Rasheed W; Alzahrani H; Alsharif F; Chaudhri N; Almohareb F; Aljurf M
Leuk Res Rep; 2021; 16():100270. PubMed ID: 34631407
[TBL] [Abstract][Full Text] [Related]
32. How should we treat the AYA patient with newly diagnosed ALL?
Boissel N
Best Pract Res Clin Haematol; 2017 Sep; 30(3):175-183. PubMed ID: 29050690
[TBL] [Abstract][Full Text] [Related]
33. Leveraging health care technology to improve health outcomes and reduce outcome disparities in AYA leukemia.
Molina JC; Rotz S
Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):573-580. PubMed ID: 38066875
[TBL] [Abstract][Full Text] [Related]
34. Increased Toxicity Among Adolescents and Young Adults Compared with Children Hospitalized with Acute Lymphoblastic Leukemia at Children's Hospitals in the United States.
Gupta A; Damania RC; Talati R; O'Riordan MA; Matloub YH; Ahuja SP
J Adolesc Young Adult Oncol; 2021 Dec; 10(6):645-653. PubMed ID: 33512257
[No Abstract] [Full Text] [Related]
35. Treatment completion, asparaginase completion, and oncologic outcomes among children, adolescents and young adults with acute lymphoblastic leukemia treated with DFCI Consortium Protocols.
Valtis YK; Flamand Y; Shimony S; Place AE; Silverman LB; Vrooman LM; Brunner AM; Sallan SE; Wadleigh M; Stone RM; DeAngelo DJ; Luskin MR
Leukemia; 2024 Mar; 38(3):482-490. PubMed ID: 38177437
[TBL] [Abstract][Full Text] [Related]
36. Optimal therapy for adolescents and young adults with acute lymphoblastic leukemia-current perspectives.
Lee JW
Blood Res; 2020 Jul; 55(S1):S27-S31. PubMed ID: 32719173
[TBL] [Abstract][Full Text] [Related]
37. Comparison of the results of the treatment of adolescents and young adults with standard-risk acute lymphoblastic leukemia with the Programa Español de Tratamiento en Hematología pediatric-based protocol ALL-96.
Ribera JM; Oriol A; Sanz MA; Tormo M; Fernández-Abellán P; del Potro E; Abella E; Bueno J; Parody R; Bastida P; Grande C; Heras I; Bethencourt C; Feliu E; Ortega JJ
J Clin Oncol; 2008 Apr; 26(11):1843-9. PubMed ID: 18398150
[TBL] [Abstract][Full Text] [Related]
38. Improved survival of adolescents and young adults patients with T-cell acute lymphoblastic leukemia.
Hanbali A; Kotb A; Fakih RE; Alfraih F; Shihata N; Rasheed W; Ahmed SO; Shaheen M; Alhayli S; Alahmari A; Alotaibi A; Alshaibani A; Albabtain A; Alfayez M; Hassan M; Alsharif F; Chaudhri N; Almohareb F; Alzahrani H; Aljurf M
Int J Hematol Oncol; 2023 Feb; 12(1):IJH42. PubMed ID: 36874377
[TBL] [Abstract][Full Text] [Related]
39. Pediatric-inspired protocols in adult acute lymphoblastic leukemia: are the results bearing fruit?
Muffly L; Curran E
Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):17-23. PubMed ID: 31808881
[TBL] [Abstract][Full Text] [Related]
40. Effect of Postreinduction Therapy Consolidation With Blinatumomab vs Chemotherapy on Disease-Free Survival in Children, Adolescents, and Young Adults With First Relapse of B-Cell Acute Lymphoblastic Leukemia: A Randomized Clinical Trial.
Brown PA; Ji L; Xu X; Devidas M; Hogan LE; Borowitz MJ; Raetz EA; Zugmaier G; Sharon E; Bernhardt MB; Terezakis SA; Gore L; Whitlock JA; Pulsipher MA; Hunger SP; Loh ML
JAMA; 2021 Mar; 325(9):833-842. PubMed ID: 33651090
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
